Chandigarh
GST No. 04AAGCB5164K1ZN
Call 08048986910 71% Response Rate
Send Enquiry
Potassium Citrate IP 1100mg + Magnesium Citrate USP 375mg + Pyridoxine Hydrochloride IP (Vitamin B6) 20mg
UT-MEG-B6 Syrup is a clinically trusted urinary alkalizer and kidney stone management formulation designed to help prevent and manage urolithiasis while promoting overall urinary tract health. This triple-action combination works synergistically to reduce urinary acidity, minimize crystal formation, and support metabolic balance.
It is widely prescribed for kidney stones, recurrent urolithiasis, hyperoxaluria, and urinary burning associated with acidic urine.
Manufactured in a WHO-GMP, USFDA, and EUGMP-certified facility, UT-MEG-B6 Syrup ensures high purity, excellent stability, and consistent therapeutic efficacy — making it ideal for PCD Pharma Franchise, third-party manufacturing, and export markets.
How Does It Work?Potassium Citrate IP 1100mg
Acts as a urinary alkalizer that increases urinary pH, helping prevent the formation of uric acid and calcium oxalate stones. It also supports dissolution of certain existing stones.
Magnesium Citrate USP 375mg
Binds with oxalates in urine and reduces calcium oxalate crystal formation, lowering the risk of recurrent stone development.
Pyridoxine Hydrochloride IP (Vitamin B6) 20mg
Helps reduce urinary oxalate production and supports metabolic processes involved in stone prevention.
Together, this advanced formula helps control urinary acidity, reduce recurrence of stones, and relieve urinary discomfort.
Key Features & Benefits✔ Effective Kidney Stone Prevention & Management
✔ Powerful Urinary Alkalizer Action
✔ Helps Reduce Calcium Oxalate & Uric Acid Stones
✔ Supports Oxalate Metabolism & Urinary Balance
✔ Ideal for Recurrent Stone Formers
✔ Pleasant Syrup Form for Easy Administration
✔ Manufactured in WHO-GMP & USFDA-Certified Facilities
✔ PCD Pharma & Third-Party Manufacturing Ready
✔ Export-Quality Standards with EUGMP Compliance
• Patients with kidney stones (calcium oxalate / uric acid)
• Recurrent urolithiasis cases
• Hyperoxaluria management
• Burning micturition due to acidic urine
• Post-stone removal recurrence prevention
Suitable for urologists, nephrologists, hospitals, wholesalers, stockists, and international importers.
Possible Side Effects (Generally Mild)• Mild gastric discomfort
• Nausea
• Abdominal bloating
• Loose motions (rare)
⚠️ Use under medical supervision, especially in patients with renal impairment or electrolyte imbalance.
Why Choose Us?✔ IP/USP Grade Quality Raw Materials
✔ Strict Quality Control & Validated Manufacturing
✔ WHO-GMP Accredited Production Facility
✔ Controlled Environmental Standards
✔ Secure, Leak-Proof & Stable Packaging
✔ Reliable Supply for Domestic & Export Markets
✔ PCD Pharma Franchise for Urology & Nephrology Segment
✔ Third-Party Manufacturing of Urinary Alkalizer Syrup
✔ Reliable Supplier of Kidney Stone Management Formulations
✔ WHO-GMP Certified Manufacturer for Export
✔ Complete Urology Range for Distributors & Stockists
View Complete details
Minimum Order Quantity: 10 Box
| Composition | Torsemide |
| Treatment | Kidney Disease |
| Brand | TORSEPOD |
| Manufacturer | BIOFIELD PHARMA |
| Packaging Size | 10*10 tablets |
| Packaging Type | Alu Alu |
| Shelf Life | 24 months |
| Grade Standard | WHO GMP |
| Usage/Application | Hospital |
TORSEPOD-10 contains Torsemide 10 mg, a potent loop diuretic indicated for the management of edema and fluid retention associated with cardiac, renal, or hepatic conditions. It supports effective fluid removal and helps reduce symptoms related to excess fluid accumulation.
Manufactured in a WHO-GMP compliant facility following stringent quality standards, TORSEPOD-10 ensures safety, consistency, and reliability for domestic and export markets.
Mechanism of Action Torsemide 10 mg (Loop Diuretic)Acts on the loop of Henle in the kidneys
Increases excretion of excess sodium and water
Reduces fluid overload and swelling
Helps decrease blood volume and cardiac workload
Supports improved symptomatic relief in fluid retention conditions
Torsemide offers effective and sustained diuretic action, making it suitable for once-daily dosing in many patients.
Key Features & BenefitsEffective management of edema and fluid overload
Potent and reliable diuretic action
Helps reduce swelling and associated discomfort
Supports improved cardiovascular and renal function
Manufactured under WHO-GMP compliant standards
Suitable for PCD Pharma Franchise & Third-Party Manufacturing
Edema associated with Congestive Heart Failure
Renal disease-related fluid retention
Hepatic cirrhosis-associated edema
Hypertension (as prescribed by a physician)
To be used strictly under medical supervision.
Possible Side EffectsGenerally well tolerated when used as directed. Some patients may experience:
Increased urination
Mild dizziness
Electrolyte imbalance (rare)
Muscle cramps or weakness
Periodic monitoring of electrolytes and kidney function is recommended during therapy.
Manufacturing & Business AdvantagesHigh-quality API procurement
Strict in-process and finished product quality checks
Advanced blister packaging for stability and shelf life
Technical documentation support available
Suitable for domestic distribution and export markets
Dosage and duration should be determined by a qualified healthcare professional based on the patient’s clinical condition. Regular monitoring is advised to ensure safe and effective therapy.
If needed, I can also prepare:
✔️ SEO-optimized website version
✔️ Distributor / stockist promotional content
✔️ Doctor detailing (MR visual aid) content
✔️ IndiaMART / TradeIndia listing description
✔️ Export-focused brochure content
Additional Information:
View Complete details
Minimum Order Quantity: 10 Box
| Composition | Torsemide |
| Treatment | Kidney Disease |
| Brand | TORSEPOD |
| Dose/Strength | 20 mg |
| Manufacturer | Biofield pharma |
| Shelf Life | 24 months |
| Grade Standard | WHO GMP |
| Usage/Application | Hospital |
TORSEPOD-20 contains Torsemide 20 mg, a potent loop diuretic indicated for the management of moderate to severe edema and fluid retention associated with cardiac, renal, or hepatic disorders. It ensures effective removal of excess fluid and helps relieve symptoms related to fluid overload.
Manufactured in a WHO-GMP compliant facility, TORSEPOD-20 guarantees superior quality, safety, and consistency for both domestic and international markets.
Mechanism of Action – Torsemide 20 mg (Loop Diuretic)Torsemide acts on the Loop of Henle in the kidneys to:
Increase excretion of sodium and water
Promote effective diuresis
Reduce excess fluid accumulation
Decrease blood volume
Lower cardiac workload
Provide symptomatic relief in edema and hypertension
Its strong and sustained diuretic effect makes it suitable for once-daily dosing in many patients, as advised by a physician.
Key Features & Benefits✔ Effective management of moderate to severe edema
✔ Potent and sustained diuretic action
✔ Helps reduce swelling and discomfort
✔ Supports improved cardiovascular and renal function
✔ Reliable fluid control in chronic conditions
✔ Manufactured under strict WHO-GMP standards
✔ Ideal for PCD Pharma Franchise & Third-Party Manufacturing
Edema associated with Congestive Heart Failure
Renal disease-related fluid retention
Hepatic cirrhosis-associated edema
Hypertension (as prescribed by a healthcare professional)
To be used strictly under medical supervision.
Possible Side EffectsGenerally well tolerated when used as directed. Some patients may experience:
Increased urination
Mild dizziness
Electrolyte imbalance (rare)
Muscle cramps or weakness
Periodic monitoring of electrolytes and renal function is recommended during therapy.
Manufacturing & Business AdvantagesPremium-quality API procurement
Strict in-process and finished product quality testing
Advanced blister packaging for enhanced stability and shelf life
Complete technical documentation support available
Suitable for domestic distribution and export markets
Dosage and duration should be determined by a qualified healthcare professional based on the patient’s clinical condition and response to therapy. Regular monitoring ensures safe and effective treatment.
Additional Information:
View Complete details